MedPath

Effects of Cisatracurium on Succinylcholine-induced Fasciculations and Myalgia

Phase 3
Completed
Conditions
Fasciculation
Interventions
Registration Number
NCT02481193
Lead Sponsor
Yangzhou No.1 People's Hospital
Brief Summary

The purpose of this study is to investigate the effects of different doses of cisatracurium pretreatment on succinylcholine-induced fasciculations and postoperative myalgia.

Detailed Description

Purpose: To investigate the effects of different doses of cisatracurium pretreatment on succinylcholine-induced fasciculations and postoperative myalgia.

Methods: Ninety patients scheduled for laparoscopic cholecystectomies were equally randomized into three groups to receive pretreatment of 0.005, 0.01, and 0.02 mg/kg cisatracurium, respectively. General anesthesia was induced 3.5 min later, train of four stimulation was monitored 4.5 min later, succinylcholine 1.5 mg/kg was injected 5 min later, and endotracheal intubation was implemented 6.5 min later. The side effects of cisatracurium, intensity of fasciculations, intubating conditions, time and extent to maximal depression of twitch and time for its recovery to 20% of control value, severity of myalgia at 24 h postoperatively, serum potassium before the induction, at the time of endotracheal intubation, and 5 min after intubation were recorded.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
90
Inclusion Criteria
  • American Standards Association (ASA) physical status I or II patients scheduled for elective laparoscopic cholecystectomies with tracheal intubation requiring general anesthesia
  • 20 - 65 years old
  • without acid-base imbalance and electrolyte disturbance
  • with normal hepatic and renal function
Exclusion Criteria
  • Patients with known hyperkalemia
  • Patients with increased intraocular pressure
  • Patients with increased intracranial pressure
  • Patients with symptoms of gastroesophageal reflux
  • Patients with anticipated airway difficulties
  • Patients with malignant fever
  • Patients with neuromuscular disease
  • Patients with burn or crush injuries
  • Patients with taking drugs known to alter the action of neuromuscular blockers
  • Patients with with a body mass index exceeding 30

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Cisatracurium 0.01 mg/kgCisatracuriumThe group received pretreatment of cisatracurium 0.01 mg/kg
Cisatracurium 0.02 mg/kgCisatracuriumThe group received pretreatment of cisatracurium 0.02 mg/kg
Cisatracurium 0.005 mg/kgCisatracuriumThe group received pretreatment of cisatracurium 0.005 mg/kg.
Primary Outcome Measures
NameTimeMethod
The presence of fasciculationsAfter the injection of succinylcholine for 1.5 minutes
Secondary Outcome Measures
NameTimeMethod
Side effects of the pretreatment of cisatracuriumAt the time of three minutes after the pretreatment of cisatracurium
The time to maximal depression of twitchFrom the time of 4.5 minutes after the pretreatment of cisatracurium for two minutes
The extent to maximal depression of twitchFrom the time of 4.5 minutes after the pretreatment of cisatracurium for two minutes
The time for twitch recovery to 20% of its control valueFrom the time of 4.5 minutes after the pretreatment of cisatracurium for two minutes
The grades of endotracheal intubationAt intubating time
The changes of serum potassiumAfter entering the operating theater till the anesthesia induction, at intubating, and 5 min after intubation
Myalgia at 24 hours postoperativelyAt 24 hours postoperatively
© Copyright 2025. All Rights Reserved by MedPath